Literature DB >> 1280260

Cleavage of tRNA by Fe(II)-bleomycin.

A Hüttenhofer1, S Hudson, H F Noller, P K Mascharak.   

Abstract

We have investigated the action of the chemotherapeutic agent Fe(II)-bleomycin on yeast tRNA(Phe), an RNA of known three-dimensional structure. In the absence of Mg2+ ions, the RNA is cleaved preferentially at two major positions, A31 and G53, both of which are located at the terminal base pairs of hairpin loops, and coincide with the location of tight Mg2+ binding sites. A fragment of the tRNA (residues 47-76) containing the T stem-loop is also cleaved specifically at G53. Cleavage of both the intact tRNA and the tRNA fragment is abolished in the presence of physiological concentrations of Mg2+ (> 0.5 mM). Since Fe(II) is not displaced from bleomycin under these conditions, we infer that tight binding of Mg2+ to tRNA excludes productive interactions between Fe(II)-bleomycin and the RNA. These results also show that loss of cleavage is not due to Mg(2+)-dependent formation of tertiary interactions between the D and T loops. In contrast, cleavage of synthetic DNA analogs of the anticodon and T stem-loops is not detectably inhibited by Mg2+, even at concentrations as high as 50 mM. In addition, the site specificities observed in cleavage of RNA and DNA differ significantly. From these results, and from similar findings with other representative RNA molecules, we suggest that the cleavage of RNA by Fe(II)-bleomycin is unlikely to be important for its therapeutic action.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280260

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  Isoalloxazine derivatives promote photocleavage of natural RNAs at G.U base pairs embedded within helices.

Authors:  P Burgstaller; T Hermann; C Huber; E Westhof; M Famulok
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

2.  Disruption of the Saccharomyces cerevisiae cell-wall pathway gene SLG1 causes hypersensitivity to the antitumor drug bleomycin.

Authors:  A Leduc; C H He; D Ramotar
Journal:  Mol Genet Genomics       Date:  2003-02-12       Impact factor: 3.291

3.  Fe.bleomycin as a probe of RNA conformation.

Authors:  C E Holmes; A T Abraham; S M Hecht; C Florentz; R Giegé
Journal:  Nucleic Acids Res       Date:  1996-09-01       Impact factor: 16.971

4.  Bleomycin therapy of experimental disseminated candidiasis in mice.

Authors:  J R Graybill; R Bocanegra; A Fothergill; M G Rinaldi
Journal:  Antimicrob Agents Chemother       Date:  1996-03       Impact factor: 5.191

Review 5.  Protective mechanisms against the antitumor agent bleomycin: lessons from Saccharomyces cerevisiae.

Authors:  Dindial Ramotar; Huijie Wang
Journal:  Curr Genet       Date:  2003-04-16       Impact factor: 3.886

6.  Oxidative cell wall damage mediated by bleomycin-Fe(II) in Saccharomyces cerevisiae.

Authors:  S T Lim; C K Jue; C W Moore; P N Lipke
Journal:  J Bacteriol       Date:  1995-06       Impact factor: 3.490

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.